Non-random Escape Pathways from a Broadly Neutralizing Human Monoclonal Antibody Map to a Highly Conserved Region on the Hepatitis C Virus E2 Glycoprotein Encompassing Amino Acids 412

Non-random Escape Pathways from a Broadly Neutralizing Human Monoclonal Antibody Map to a Highly Conserved Region on the Hepatitis C Virus E2 Glycoprotein Encompassing Amino Acids 412–423

Published:2014-08-14 Issue:8 Volume:10 Page:e1004297
ISSN:1553-7374
Container-title:PLoS Pathogens
language:en
Short-container-title:PLoS Pathog

Author:

Keck Zhen-yong,Angus Allan G. N.,Wang Wenyan,Lau Patrick,Wang Yong,Gatherer Derek,Patel Arvind H.,Foung Steven K. H.

Publisher

Public Library of Science (PLoS)

Subject

Virology,Genetics,Molecular Biology,Immunology,Microbiology,Parasitology

Reference62 articles.

1. World Health Organization. Hepatitis C. Fact sheet number 164. http://who.int/mediacentre/factsheets/fs164/en/#content (2013). WHO website (online).

2. Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment options;IM Jacobson;N Engl J Med,2013

3. Nucleotide polymerase inhibitor sofosbuvir plus ribavirin for hepatitis C;EJ Gane;N Engl J Med

4. Sofosbuvir for previously untreated chronic hepatitis C infection;E Lawitz;N Engl J Med,2013

5. Current and future therapies for hepatitis C virus infection;TJ Liang;N Engl J Med,2013

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Review on cLF36, a Novel Recombinant Antimicrobial Peptide-Derived Camel Lactoferrin;Probiotics and Antimicrobial Proteins;2024-05-09

2. HCV E1 influences the fitness landscape of E2 and may enhance escape from E2-specific antibodies;Virus Evolution;2023-07-01

3. Current Hepatitis C Vaccine Candidates Based on the Induction of Neutralizing Antibodies;Viruses;2023-05-11

4. Effect of Glycan Shift on Antibodies against Hepatitis C Virus E2 412–425 Epitope Elicited by Chimeric sHBsAg-Based Virus-Like Particles;Microbiology Spectrum;2023-04-13

5. Identification of novel neutralizing determinants for protection against HCV;Hepatology;2023-02-17